A. Bauer-Mehren

发表

Gene-Disease Network Analysis Reveals Functional Modules in Mendelian, Complex and Environmental Diseases

A. Bauer-Mehren, Markus Bundschus, Michael Rautschka, 2011, PloS one.

Performance of Pharmacovigilance Signal‐Detection Algorithms for the FDA Adverse Event Reporting System

N. Shah, W. DuMouchel, R. Harpaz, 2013, Clinical pharmacology and therapeutics.

Pathway databases and tools for their exploitation: benefits, current limitations and challenges

A. Bauer-Mehren, F. Sanz, L. Furlong, 2009, Molecular systems biology.

Profiling risk factors for chronic uveitis in juvenile idiopathic arthritis: a new model for EHR-based research

N. Shah, A. Bauer-Mehren, P. LePendu, 2013, Pediatric Rheumatology.

Pharmacovigilance Using Clinical Notes

N. Shah, R. Harpaz, A. Bauer-Mehren, 2013, Clinical pharmacology and therapeutics.

Learning Signals of Adverse Drug-Drug Interactions from the Unstructured Text of Electronic Health Records

N. Shah, R. Harpaz, A. Bauer-Mehren, 2013, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.

Regulatory T-cell Genes Drive Altered Immune Microenvironment in Adult Solid Cancers and Allow for Immune Contextual Patient Subtyping

J. Dudley, A. Bauer-Mehren, Wei-Yi Cheng, 2017, Cancer Epidemiology, Biomarkers & Prevention.

Practice-Based Evidence: Profiling the Safety of Cilostazol by Text-Mining of Clinical Notes

Nigam H. Shah, Paea LePendu, Anna Bauer-Mehren, 2013, PloS one.

Network analysis of unstructured EHR data for clinical research

N. Shah, R. Harpaz, A. Bauer-Mehren, 2013, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.

The EU‐ADR Web Platform: delivering advanced pharmacovigilance tools

J. Oliveira, J. Lei, J. Mestres, 2013, Pharmacoepidemiology and drug safety.

Prior fluid and electrolyte imbalance is associated with COVID-19 mortality

A. Bauer-Mehren, Satu Nahkuri, S. Massberg, 2021, Communications Medicine.

Prediction of 60 day case-fatality after aneurysmal subarachnoid haemorrhage: results from the International Subarachnoid Aneurysm Trial (ISAT)

Hester F. Lingsma, E. Steyerberg, A. Bauer-Mehren, 2010, European Journal of Epidemiology.

A Novel Multilevel Statistical Method for the Study of the Relationships between Multireceptorial Binding Affinity Profiles and In Vivo Endpoints

A. Bauer-Mehren, F. Sanz, M. Loza, 2010, Molecular Pharmacology.

Fluid, pH and electrolyte imbalance associated with COVID-19 mortality

A. Bauer-Mehren, Satu Nahkuri, S. Massberg, 2021 .

DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes

Núria Queralt-Rosinach, Laura Inés Furlong, Àlex Bravo, 2015, Database J. Biol. Databases Curation.

DisGeNET: a Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks

Laura Inés Furlong, Anna Bauer-Mehren, Ferran Sanz, 2010, Bioinform..

Drug-Induced Acute Myocardial Infarction: Identifying ‘Prime Suspects’ from Electronic Healthcare Records-Based Surveillance System

Scott Boyer, Martijn J. Schuemie, Jordi Mestres, 2013, PloS one.

Deep Learning-based Propensity Scores for Confounding Control in Comparative Effectiveness Research

Fabian J Theis, A. Bauer-Mehren, F. Schmich, 2021, Epidemiology.

Integration of genomic information with biological networks using Cytoscape.

Anna Bauer-Mehren, A. Bauer-Mehren, 2013, Methods in molecular biology.

Mining clinical text for signals of adverse drug-drug interactions

Nigam H. Shah, Paea LePendu, Anna Bauer-Mehren, 2014, J. Am. Medical Informatics Assoc..

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population

Nigam H. Shah, Paea LePendu, Anna Bauer-Mehren, 2015, PloS one.

Correction: Automatic Filtering and Substantiation of Drug Safety Signals

Scott Boyer, Jan A. Kors, Laura I. Furlong, 2012, PLoS Computational Biology.

From SNPs to pathways: integration of functional effect of sequence variations on models of cell signalling pathways

Laura Inés Furlong, Ferran Sanz, Anna Bauer-Mehren, 2009, BMC Bioinformatics.

Artificial Intelligence for Prognostic Scores in Oncology: a Benchmarking Study

Narges Ahmidi, Anna Bauer-Mehren, Hugo Loureiro, 2021, Frontiers in Artificial Intelligence.

An Enhanced Prognostic Score for Overall Survival of Patients with Cancer Derived from a large Real World Cohort.

A. Bauer-Mehren, F. Schmich, J. Weberpals, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Deep Learning-based Propensity Scores for Confounding Control in Comparative Effectiveness Research A Large-scale, Real-world Data Study

A. Bauer-Mehren, F. Schmich, J. Weberpals, 2021 .

Gathering and Exploring Scientific Knowledge in Pharmacovigilance

Scott Boyer, José Luís Oliveira, Gayo Diallo, 2013, PloS one.

Correction: Automatic Filtering and Substantiation of Drug Safety Signals

Erik M. van Mullingen, J. Mestres, S. Boyer, 2012, PLoS Computational Biology.

Automatic Filtering and Substantiation of Drug Safety Signals

Laura Inés Furlong, Scott Boyer, José Luís Oliveira, 2012, PLoS Comput. Biol..

Pharmacovigilance using Clinical Text

Paea LePendu, Anna Bauer-Mehren, Nigam H Shah, 2013, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.

Learning Drug-Drug Interactions from the Unstructured Text of Electronic Health Records

R. Harpaz, A. Bauer-Mehren, P. LePendu, 2012 .

Functional evaluation of out-of-the-box text-mining tools for data-mining tasks

Bethany Percha, Nigam H. Shah, Kenneth Jung, 2014, J. Am. Medical Informatics Assoc..

Pump Inhibitor the in the General

A. Bauer-Mehren, P. LePendu, Srini Iyer, 2015 .